Overview
Daska Buzina practices practicing medicine in Zagreb, Croatia.
Their clinical expertise encompasses Muir-Torre Syndrome, Calciphylaxis, Lichen Sclerosus, and Melanoma.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Daska S. Buzina
Is Daska S. Buzina a top-rated expert for Muir-Torre Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Daska S. Buzina is classified as an Experienced expert for Muir-Torre Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Daska S. Buzina participate in research or clinical trials?
Yes. Daska S. Buzina has published 11 articles and abstracts on conditions like Muir-Torre Syndrome. You can view a list of Daska S. Buzina's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CalciphylaxisBuzina isExperienced. Learn about Calciphylaxis.
- Lichen SclerosusBuzina isExperienced. Learn about Lichen Sclerosus.
- MelanomaBuzina isExperienced. Learn about Melanoma.
- Muir-Torre SyndromeBuzina isExperienced. Learn about Muir-Torre Syndrome.